August 09,2007
Grassley Seeks FDA Briefing on Steps to Ensure Safety of Foreign-made Medicine
WASHINGTON – Sen. Chuck Grassley, ranking member of the Committee on Finance, is asking the Food and Drug Administration for an explanation of its steps to ensure the safety of foreign-made medicine. In a letter to the agency commissioner, Grassley said he is disturbed by reports of the inadequacy of FDA inspections of foreign pharmaceutical manufacturing facilities, especially given the growing predominance of overseas manufacturing of such products.
The text of Grassley’s letter follows here.
###
Next Article Previous Article
Recent News
- Wyden: Republicans Vote for Trump’s Tariffs and Higher Prices, Instead of Supporting American Jobs and Families
- Wyden Urges Congress to Reassert Trade Authority Amid Trump's Global Tariffs Crashing the Economy
- Wyden Opposes Nomination of Scott as CBP Commissioner at Finance Committee Hearing
- Wyden, Colleagues, Slam Trump Administration’s Plan to Dismantle Federal Agency that Helps Seniors Live Independently, Stay in their Homes as they Age
- Wyden Opposes Tax and Trade Nominees, Blasts Trump’s Disastrous Economic Agenda